Radcliffe Capital Management’s GP-Act III Acquisition Corp GPAT Stock Holding History
Bought
Maintained
Sold
Other funds holding GPAT
KIM
FTCM
AIMCA
AA
PMAM
MI
LP
PAMP
WC
Radcliffe Capital Management's GPAT Position: Q1 2026 in Review
Radcliffe Capital Management increased its GP-Act III Acquisition Corp (GPAT) stake by 8.7% in Q1 2026, buying an estimated $539K and bringing the position to 623,267 shares worth $6.76M. The position accounts for 0.51% of the portfolio, ranked #27.
Radcliffe Capital Management first reported a position in GPAT in Q2 2025 and has held it in 4 quarters since. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.
- Radcliffe Capital Management held 623,267 shares of GP-Act III Acquisition Corp worth $6.76M as of Q1 2026.
- Radcliffe Capital Management bought 50,045 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $539K.
- GP-Act III Acquisition Corp made up 0.51% of Radcliffe Capital Management's portfolio in Q1 2026, its #27 holding.
- Radcliffe Capital Management first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 4 quarters since.
- 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.
Based on Radcliffe Capital Management's 13F filing for Q1 2026, filed 15 May 2026.